InMed Pharmaceuticals (INM) Shareholder's Equity (2019 - 2026)
InMed Pharmaceuticals (INM) Shareholder's Equity (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - | 6.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 11.59 Mn |
| Jun 30, 2025 | 13.43 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 9.21 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 30, 2023 | -9.58 Mn |
| Jun 30, 2023 | 12.09 Mn |
| Mar 31, 2023 | 12.39 Mn |
| Dec 31, 2022 | 14.34 Mn |
| Sep 30, 2022 | 11.01 Mn |
| Jun 30, 2022 | 9.08 Mn |
| Mar 31, 2022 | 10.89 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Sep 30, 2021 | 15.22 Mn |
| Jun 30, 2021 | 7.38 Mn |